Seattle Genetics (SGEN) Tops Q4 EPS by 11c; Guides Above for FY10 Revenues
Tweet Send to a Friend
Seattle Genetics (NASDAQ: SGEN) reports a Q4 loss of $0.12, 11 cents better than the analyst estimate of ($0.23) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
